High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS

Схожие документы

• Interferon-gamma (IFNy) in macrophage activation syndrome (MAS) associated with systemic juvenile idiopathic arthritis (sJIA). High levels in patients and a role in a murine mas model
  по: Bracaglia, Claudia, et al.
  Опубликовано: (2014)
• Anti interferon-gamma (IFNγ) monoclonal antibody treatment in a patient carrying an NLRC4 mutation and severe hemophagocytic lymphohistiocytosis
  по: Bracaglia, C, et al.
  Опубликовано: (2015)
• Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis
  по: Buatois, Vanessa, et al.
  Опубликовано: (2017)
• Involvement of the IFN-gamma pathway in a patient with candle syndrome carrying a novel variant of PSMB8 gene
  по: Insalaco, Antonella, et al.
  Опубликовано: (2014)
• Neutralization of Interferon-gamma is efficacious in a mouse model of HLH secondary to chronic inflammation
  по: Prencipe, G, et al.
  Опубликовано: (2015)